Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,564
  • Shares Outstanding, K 1,935
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,530 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1200 +18.30%
on 12/24/25
2.1300 -37.79%
on 11/28/25
-0.9050 (-40.58%)
since 11/26/25
3-Month
1.1200 +18.30%
on 12/24/25
4.4200 -70.02%
on 09/29/25
-2.9650 (-69.11%)
since 09/26/25
52-Week
1.1200 +18.30%
on 12/24/25
14.2800 -90.72%
on 05/19/25
-6.1258 (-82.22%)
since 12/26/24

Most Recent Stories

More News
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice

NEW YORK, NY / ACCESS Newswire / November 27, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") today announced that it has received a notification letter from the Nasdaq Listing Qualifications...

PTGX : 88.78 (-0.07%)
PTIX : 1.3250 (+15.22%)
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office...

PTIX : 1.3250 (+15.22%)
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price

PTIX : 1.3250 (+15.22%)
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders,...

PTIX : 1.3250 (+15.22%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled...

TRIQ : 0.4000 (-27.27%)
DMIFF : 0.0070 (+75.00%)
PBLA : 0.0011 (+266.67%)
THBRF : 1.1406 (-0.82%)
ATGN : 0.4674 (+1.10%)
STRR : 10.92 (-0.09%)
ADXN : 7.99 (-2.56%)
MKTY : 12.66 (-1.40%)
BTX : 6.71 (unch)
FLUX : 1.4000 (unch)
NMTC : 0.7297 (-4.71%)
NEPH : 4.93 (-5.74%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual...

DMIFF : 0.0070 (+75.00%)
PBLA : 0.0011 (+266.67%)
ATGN : 0.4674 (+1.10%)
STRR : 10.92 (-0.09%)
ADXN : 7.99 (-2.56%)
MKTY : 12.66 (-1.40%)
FLUX : 1.4000 (unch)
NMTC : 0.7297 (-4.71%)
NEPH : 4.93 (-5.74%)
ACER : 0.6601 (-17.95%)
BSFC : 0.0025 (unch)
DTST : 5.07 (+0.80%)

Business Summary

Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based...

See More

Key Turning Points

3rd Resistance Point 1.6333
2nd Resistance Point 1.4917
1st Resistance Point 1.4083
Last Price 1.3250
1st Support Level 1.1833
2nd Support Level 1.0417
3rd Support Level 0.9583

See More

52-Week High 14.2800
Fibonacci 61.8% 9.2529
Fibonacci 50% 7.7000
Fibonacci 38.2% 6.1471
Last Price 1.3250
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar